Neuroendocrine Tumors: Is There a Standard Treatment?

by Kulke, Matthew H.
Published 2008

Systemic Therapy for Advanced Pancreatic Neuroendocrine Tumors

by Kulke, Matthew H.
Published 2013

Accomplishments in 2008 in the Management of Gastrointestinal Neuroendocrine Tumors

by Kulke, Matthew H., Scherübl, Hans
Published 2009

Targeted Therapy in Advanced Well-Differentiated Neuroendocrine Tumors

by Raut, Chandrajit P., Kulke, Matthew H.
Published 2011

Progress in the Treatment of Neuroendocrine Tumors

by Chan, Jennifer A., Kulke, Matthew H.
Published 2009

In Reply

by Yao, James, Reidy Lagunes, Diane, Kulke, Matthew H.
Published 2013

Targeted Therapies in Neuroendocrine Tumors (NET): Clinical Trial Challenges and Lessons Learned

by Yao, James C., Lagunes, Diane Reidy, Kulke, Matthew H.
Published 2013

Evolving Diagnostic and Treatment Strategies for Pancreatic Neuroendocrine Tumors

by Kulke, Matthew H, Bendell, Johanna, Kvols, Larry, Picus, Joel, Pommier, Rodney, Yao, James
Published 2011

Phase I study of sorafenib in combination with everolimus (RAD001) in patients with advanced neuroendocrine tumors

by Chan, Jennifer A., Mayer, Robert J., Jackson, Nadine, Malinowski, Paige, Regan, Eileen, Kulke, Matthew H.
Published 2013

Drug-related pneumonitis during mTOR inhibitor therapy in patients with neuroendocrine tumors: A radiographic pattern-based approach

by Nishino, Mizuki, Brais, Lauren K., Brooks, Nichole V., Hatabu, Hiroto, Kulke, Matthew H., Ramaiya, Nikhil H.
Published in Eur J Cancer (2016)

Elimination of unaltered DNA in mixed clinical samples via nuclease-assisted minor-allele enrichment

by Song, Chen, Liu, Yibin, Fontana, Rachel, Makrigiorgos, Alexander, Mamon, Harvey, Kulke, Matthew H., Makrigiorgos, G. Mike
Published in Nucleic Acids Res (2016)

Whole Genome Amplification of Plasma-Circulating DNA Enables Expanded Screening for Allelic Imbalance in Plasma

by Li, Jin, Harris, Lyndsay, Mamon, Harvey, Kulke, Matthew H., Liu, Wei-Hua, Zhu, Penny, Mike Makrigiorgos, G.
Published 2006

Treatment Outcomes in Patients with Metastatic Neuroendocrine Tumors: a Retrospective Analysis of a Community Oncology Database

by Fisher, Maxine D., Pulgar, Sonia, Kulke, Matthew H., Mirakhur, Beloo, Miller, Paul J., Walker, Mark S., Schwartzberg, Lee S.
Published in J Gastrointest Cancer (2018)

The NANETS Consensus Guidelines for the Diagnosis and Management of Poorly Differentiated (High-Grade) Extrapulmonary Neuroendocrine Carcinomas

by Strosberg, Jonathan R., Coppola, Domenico, Klimstra, David S., Phan, Alexandria T., Kulke, Matthew H., Wiseman, Gregory A., Kvols, Larry K.
Published 2010

Profiling of metastatic small intestine neuroendocrine tumors reveals characteristic miRNAs detectable in plasma

by Bowden, Michaela, Zhou, Chensheng W., Zhang, Sui, Brais, Lauren, Rossi, Ashley, Naudin, Laurent, Thiagalingam, Arunthi, Sicinska, Ewa, Kulke, Matthew H.
Published in Oncotarget (2017)

Treatment Patterns and Health Resource Use Among Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors Treated at a Tertiary Referral Center

by Jalbert, Jessica J., Casciano, Roman, Meng, Jie, Brais, Lauren K., Pulgar, Sonia J., Berthon, Anthony, Dinet, Jerome, Kulke, Matthew H.
Published in Oncologist (2020)

Clinical Benefits of Above-Standard Dose of Octreotide LAR in Patients With Neuroendocrine Tumors for Control of Carcinoid Syndrome Symptoms: A Multicenter Retrospective Chart Revi...

by Strosberg, Jonathan R., Benson, Al B., Huynh, Lynn, Duh, Mei Sheng, Goldman, Jamie, Sahai, Vaibhav, Rademaker, Alfred W., Kulke, Matthew H.
Published 2014

Hoxc6 is overexpressed in gastrointestinal carcinoids and interacts with JunD to regulate tumor growth

by Fujiki, Kotoyo, Duerr, Eva-Maria, Kikuchi, Hirotoshi, Ng, Aylwin, Xavier, Ramnik J., Mizukami, Yusuke, Imamura, Takaaki, Kulke, Matthew H., Chung, Daniel C.
Published 2008

Phase II study of pemetrexed in patients with advanced neuroendocrine tumors

by Chan, Jennifer A., Zhu, Andrew X., Stuart, Keith, Bhargava, Pankaj, Earle, Craig C., Clark, Jeffrey W., Casey, Carolyn, Regan, Eileen, Kulke, Matthew H.
Published 2010

A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumors

by Kulke, Matthew H., Chan, Jennifer A., Meyerhardt, Jeffrey A., Zhu, Andrew X., Abrams, Thomas A., Blaszkowsky, Lawrence S., Regan, Eileen, Sidor, Carolyn, Fuchs, Charles S.
Published 2010